Sec. 802. Ensuring completion of pediatric study requirements
339 words·~2 min read·
/bill/119/s/891/is/section-802A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 505B(d) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355c(d) ) is amended— in paragraph (1), by striking Beginning 270 and inserting ; Noncompliance letter.— Beginning 270 in paragraph (2)— by striking The drug or and inserting ; and Effect of noncompliance.— The drug or by striking (except that the drug or biological product shall not be subject to action under section 303) and inserting (except that the drug or biological product shall be subject to action under section 303 only if such person demonstrated a lack of due diligence in satisfying the applicable requirement) ; and by adding at the end the following:
The Secretary shall not issue enforcement actions under section 303 for failures under this subsection in the case of a drug or biological product that is no longer marketed. . Section 505B(d) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355c(d) ), as amended by subsection (a), is further amended by adding at the end the following: Before the Secretary may conclude that a person failed to submit or otherwise meet a requirement as described in the matter preceding paragraph (1), the Secretary shall— issue a noncompliance letter pursuant to paragraph (1); provide such person with a 45-day period beginning on the date of receipt of such noncompliance letter to respond in writing as set forth in such paragraph; and after reviewing such written response, determine whether the person demonstrated a lack of due diligence in satisfying such requirement. .
Section 303(f)(4)(A) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 333(f)(4)(A) ) is amended by striking or 505–1 and inserting 505–1, or 505B . The Secretary of Health and Human Services may take enforcement action under section 303 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 333 ) only for failures described in section 505B(d) of such Act ( 21 U.S.C. 355c(d) ) that occur on or after the date that is 180 days after the date of enactment of this Act.
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources